CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Erchonia LUNULAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02588599
NCT02588599N/ACompleted
CompareCT.gov

A Retrospective Evaluation of the Effect of the Erchonia LUNULA™ on the Increase of Clear Nail in Patients With Toenail Onychomycosis

Erchonia Corporation·interventional·Posted Oct 28, 2015·Updated Sep 28, 2016

In Brief

A clinical study evaluating Erchonia LUNULA for Onychomycosis. Completed, enrolled 54 participants.

Detailed Summary

The purpose of this study is to determine whether low level laser therapy (LLLT) using the Erchonia LUNULA device is effective in increasing clear nail in toenails with onychomycosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 28, 2015
Enrollment StartOct 1, 2015
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 10.7 years ago

Interventions

Erchonia LUNULAdevice

Active low level laser light therapy